Access Statistics for Christopher Mark Snyder

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Advance Market Commitments: Insights from Theory and Experience 0 0 0 30 0 2 12 126
An Empirical Study of Pricing Strategies in an Online Market with High-Frequency Price Information 0 0 1 35 2 3 14 268
An Optimal Mechanism to Fund the Development of Vaccines Against Emerging Epidemics 0 0 0 18 1 6 15 26
Authors' response to Unjournal evaluations of "Advance Market Commitments: Insights from Theory and Practice" 0 0 1 1 0 3 13 15
Calculating the Costs and Benefits of Advance Preparations for Future Pandemics 0 0 0 18 2 7 15 45
Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines? 0 0 0 2 5 5 14 18
Cite Unseen: Theory and Evidence on the Effect of Open Access on Cites to Academic Articles Across the Quality Spectrum 0 0 0 10 0 4 22 54
Cite unseen: Theory and evidence on the effect of open access on cites to academic articles across the quality spectrum 0 0 0 0 0 0 6 14
Communication in Vertical Markets: Experimental Evidence 0 0 0 35 5 7 26 86
Communication in Vertically Related Markets: Experimental Evidence 0 0 0 29 0 0 6 36
Communication in vertical markets: Experimental evidence 0 0 0 50 7 11 39 108
Costs of Managerial Attention and Activity as a Source of Sticky Prices: Structural Estimates from an Online Market 0 0 0 16 3 3 9 52
Costs of Managerial Attention and Activity as a Source of Sticky Prices: Structural Estimates from an Online Market 0 0 0 9 2 4 9 42
Could Vaccine Dose Stretching Reduce COVID-19 Deaths? 0 0 0 7 0 0 4 52
Could Vaccine Dose Stretching Reduce COVID-19 Deaths? 0 0 0 10 4 5 13 52
Designing Advance Market Commitments for New Vaccines 1 1 4 37 4 6 38 134
Designing Advance Market Commitments for New Vaccines 0 0 0 6 4 7 13 41
Do Buyer-Size Discounts Depend on the Curvature of the Surplus Function? Experimental Tests of Bargaining Models 0 0 1 71 3 4 12 435
Does Online Availability Increase Citations? Theory and Evidence from a Panel of Economics and Business Journals 0 1 1 5 2 3 9 35
Expanding Capacity for Vaccines Against Covid-19 and Future Pandemics: A Review of Economic Issues 0 0 0 10 0 0 10 39
IDENTIFYING THE EFFECT OF OPEN ACCESS ON CITATIONS USING A PANEL OF SCIENCE JOURNALS 0 0 0 1 0 1 13 19
Information Sharing and Competition in the Motor Vehicle Industry 0 0 0 2 1 2 12 41
Information sharing and competition in the motor vehicle industry 0 0 0 252 1 3 13 1,104
Investing in Vaccines to Mitigate Harm from COVID-19 and Future Pandemics 0 0 0 7 2 3 10 16
Money Isn’t Everything: Estimating the Prestige Value of Winning Cutthroat Kitchen from Overbidding in Sabotage Auctions 0 0 0 3 3 4 12 16
Open Access as a Crude Solution to a Hold-Up Problem in the Two-Sided Market for Academic Journals 0 0 0 0 2 2 5 8
Open Access as a Crude Solution to a Hold-up Problem in the Two-Sided Market for Academic Journals 0 0 0 66 5 8 22 77
Open Access as a Crude Solution to a Hold‐Up Problem in the Two‐Sided Market for Academic Journals 0 0 0 0 3 4 10 13
Optimal Subsidies for Prevention of Infectious Disease 0 0 0 5 3 5 11 39
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases 0 0 0 17 1 3 10 41
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases 0 0 0 19 1 5 17 76
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 0 26 5 6 11 89
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 0 2 0 1 4 14
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 0 11 0 1 9 89
Preventives Versus Treatments 0 0 0 32 3 7 16 161
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global D 0 0 1 15 2 5 13 61
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals 0 0 0 45 0 1 9 99
Property Rights and Incomplete Contracts: Dealing with Nuisance 0 0 0 0 1 1 7 1,032
Property Rights, Incomplete Contracts, and Social Harm 0 0 0 0 0 1 8 829
Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development 0 0 1 7 2 6 18 30
Revealed Growth: A Method for Bounding the Elasticity of Demand with an Application to Assessing the Antitrust Remedy in the Du Pont Decision 0 0 0 14 3 3 5 19
Round Bidding in Auctions 0 4 8 8 2 5 18 18
Sniff Tests as a Screen in the Publication Process: Throwing out the Wheat with the Chaff 0 0 0 14 3 4 10 52
Sniff Tests in Economics: Aggregate Distribution of Their Probability Values and Implications for Publication Bias 0 0 0 11 2 2 11 31
Targeting Employees for Corporate Crime and Preventing Their Indemnification 0 0 0 0 1 1 3 6
Testing Fractional doses of COVID-19 Vaccines 0 0 0 7 3 4 16 56
Testing fractional doses of COVID-19 vaccines 0 0 0 3 3 8 15 31
The Economics of Open-Access Journals 0 0 0 131 3 14 25 516
The Economics of Open-Access Journals 0 0 0 0 1 2 11 18
Vaccines vs. Preventives 0 0 0 10 5 11 18 78
When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity 0 0 0 21 2 9 19 118
When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity 0 0 0 1 3 4 8 38
When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity - Working Paper 334 0 0 0 26 1 8 17 76
When is Prevention More Profitable than Cure? 0 0 0 6 1 4 10 68
When is Prevention More Profitable than Cure? 0 0 0 0 1 3 15 19
Why Are Drugs More Profitable Than Vaccines? 0 0 0 129 5 14 37 514
Why is There No AIDS Vaccine? 0 0 0 8 2 3 14 87
Worst-Case Bounds on R&D and Pricing Distortions: Theory with an Application Assuming Consumer Values Follow the World Income Distribution 0 0 0 21 6 7 12 61
Total Working Papers 1 6 18 1,319 126 255 793 7,338
1 registered items for which data could not be found

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
2004 International industrial organization conference 0 0 0 2 5 7 10 22
A Dynamic Theory of Countervailing Power 0 0 3 273 2 6 14 1,614
A Simple Method for Bounding the Elasticity of Growing Demand with Applications to the Analysis of Historic Antitrust Cases 0 0 0 10 1 2 7 30
A solution to the hold-up problem involving gradual investment 0 0 2 63 3 6 15 252
Academic Journal Prices in a Digital Age: A Two-Sided Market Model 0 0 1 77 1 4 10 257
Advance Market Commitments: Insights from Theory and Experience 0 1 2 25 1 8 20 113
An empirical analysis of information sharing among U.S. automakers 0 0 0 0 1 1 5 11
An optimal mechanism to fund the development of vaccines against emerging epidemics 0 0 0 1 1 4 14 26
Bidding behavior in the department of defense's commercial activities competitions 0 0 0 0 2 6 12 87
Bounding the benefits of stochastic auditing: The case of risk-neutral agents 0 0 0 67 2 5 13 479
Bounding the relative profitability of price discrimination 0 0 0 25 1 1 6 114
COUNTERVAILING POWER IN WHOLESALE PHARMACEUTICALS* 0 0 1 46 1 6 23 261
Calculating the Costs and Benefits of Advance Preparations for Future Pandemics 0 0 2 5 5 7 26 44
Can Operation Warp Speed Serve as a Model for Accelerating Innovations beyond COVID Vaccines? 0 0 2 3 2 3 16 22
Cite unseen: Theory and evidence on the effect of open access on cites to academic articles across the quality spectrum 0 0 0 0 0 1 10 18
Collusion with secret price cuts: an experimental investigation 2 2 3 174 3 6 17 950
Communication in vertical markets: Experimental evidence 0 0 2 41 4 7 20 188
Designing Advance Market Commitments for New Vaccines 0 0 2 4 3 8 19 27
Do buyer-size discounts depend on the curvature of the surplus function? Experimental tests of bargaining models 0 0 0 4 2 4 12 49
Does Online Availability Increase Citations? Theory and Evidence from a Panel of Economics and Business Journals 0 1 1 43 4 11 27 216
Dynamic Adjustment in the U.S. Higher Education Industry, 1955--1997 0 0 0 48 4 4 9 234
Expanding capacity for vaccines against Covid-19 and future pandemics: a review of economic issues 0 0 0 2 2 2 9 21
Hope Therapy in a Community Sample: A Pilot Investigation 1 1 4 60 6 10 25 207
IDENTIFYING THE EFFECT OF OPEN ACCESS ON CITATIONS USING A PANEL OF SCIENCE JOURNALS 0 0 0 8 2 2 18 93
Information Sharing and Competition in the Motor Vehicle Industry 0 1 3 82 2 4 16 334
International industrial organization conference 0 0 0 0 3 4 7 52
International industrial organization conference (5th annual) 0 0 0 1 5 7 9 25
Introduction to the 2003 International Industrial Organization Conference Special Issue 0 0 0 10 0 0 5 74
Introduction to the 2003 International Industrial Organization Conference Special Issue 0 0 0 18 2 3 7 117
Introduction to the 2004 International Industrial Organization Conference Special Issue 0 0 0 19 3 3 8 128
Introduction to the 2005 International Industrial Organization Conference Special Issue 0 0 0 24 6 6 8 130
Introduction to the Special Issue on “The Intersection Between Industrial Organization and Healthcare Economics” 0 0 0 10 4 8 18 71
Is No. News Bad News? Information Transmission and the Role of "Early Warning" in the Principal-Agent Model 0 0 3 193 2 5 19 966
Loan Commitments and the Debt Overhang Problem 0 0 0 4 2 2 7 42
Multiproject contact in research joint ventures: evidence and theory 0 0 0 17 3 9 16 119
Negotiation and Renegotiation of Optimal Financial Contracts under the Threat of Predation 0 0 0 28 0 6 14 134
Open Access and Academic Journal Quality 0 0 1 36 0 2 9 213
Open Access as a Crude Solution to a Hold‐Up Problem in the Two‐Sided Market for Academic Journals 0 0 0 9 1 4 12 54
Optimal Vaccine Subsidies for Epidemic Diseases 0 0 2 14 10 13 36 65
Optimal vaccine subsidies for endemic diseases 0 0 0 4 2 15 30 40
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 0 18 4 7 17 69
Preventives Versus Treatments 0 0 0 42 5 10 20 291
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals 0 0 0 8 5 9 17 71
Quantifying the social value of a universal COVID-19 vaccine and incentivizing its development 0 0 1 2 2 4 12 14
Reducing Government Spending With Privatization Competitions: A Study Of The Department Of Defense Experience 0 0 0 48 3 3 8 302
Should Firms be Allowed to Indemnify Their Employees for Sanctions? 0 0 0 17 1 4 10 186
THE INFLUENCE OF EXPERT REVIEWS ON CONSUMER DEMAND FOR EXPERIENCE GOODS: A CASE STUDY OF MOVIE CRITICS* 0 0 4 273 6 14 38 1,027
Testing fractional doses of COVID-19 vaccines 0 0 0 2 4 6 11 26
The Role Of Firm Size In Bilateral Bargaining: A Study Of The Cable Television Industry 1 6 13 349 5 13 36 922
The identity of the generator in the problem of social cost 0 0 0 13 3 3 7 125
Vertical Foreclosure in Experimental Markets 0 0 0 0 1 3 11 531
Why do larger buyers pay lower prices? Intense supplier competition 0 0 0 158 1 2 10 408
Total Journal Articles 4 12 52 2,380 143 290 775 11,871

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Can Operation Warp Speed Serve as a Model for Accelerating Innovations beyond COVID Vaccines? 0 0 0 4 1 1 13 27
Corporate Crime 0 0 2 43 1 2 8 93
Total Chapters 0 0 2 47 2 3 21 120

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-05-06